UNIHEALTH2025-10-012026-03-31UNIHEALTH2026-03-31UNIHEALTH2025-03-31UNIHEALTH2025-04-012026-03-31UNIHEALTH2025-10-012026-03-31in-capmkt:OtherExpenses1MemberUNIHEALTH2025-04-012026-03-31in-capmkt:OtherExpenses1MemberUNIHEALTH2026-03-31OtherNoncurrentFinancialAssetsDomain1UNIHEALTH2026-03-31OtherCurrentFinancialAssetsDomain1UNIHEALTH2026-03-31OtherCurrentAssetsDomain1UNIHEALTH2026-03-31OtherCurrentFinancialLiabilitiesDomain1UNIHEALTH2026-03-31OtherCurrentLiabilitiesDomain1UNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-04-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments1MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments2MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments3MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments4MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments5MemberUNIHEALTH2025-10-012026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2026-03-31in-capmkt:ReportableSegments6MemberUNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain1UNIHEALTH2025-09-30RelatedPartyTransactionDomain1UNIHEALTH2026-03-31RelatedPartyTransactionDomain1UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain2UNIHEALTH2025-09-30RelatedPartyTransactionDomain2UNIHEALTH2026-03-31RelatedPartyTransactionDomain2UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain3UNIHEALTH2025-09-30RelatedPartyTransactionDomain3UNIHEALTH2026-03-31RelatedPartyTransactionDomain3UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain4UNIHEALTH2025-09-30RelatedPartyTransactionDomain4UNIHEALTH2026-03-31RelatedPartyTransactionDomain4UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain5UNIHEALTH2025-09-30RelatedPartyTransactionDomain5UNIHEALTH2026-03-31RelatedPartyTransactionDomain5UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain6UNIHEALTH2025-09-30RelatedPartyTransactionDomain6UNIHEALTH2026-03-31RelatedPartyTransactionDomain6UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain7UNIHEALTH2025-09-30RelatedPartyTransactionDomain7UNIHEALTH2026-03-31RelatedPartyTransactionDomain7UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain8UNIHEALTH2025-09-30RelatedPartyTransactionDomain8UNIHEALTH2026-03-31RelatedPartyTransactionDomain8UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain9UNIHEALTH2025-09-30RelatedPartyTransactionDomain9UNIHEALTH2026-03-31RelatedPartyTransactionDomain9UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain10UNIHEALTH2025-09-30RelatedPartyTransactionDomain10UNIHEALTH2026-03-31RelatedPartyTransactionDomain10UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain11UNIHEALTH2025-09-30RelatedPartyTransactionDomain11UNIHEALTH2026-03-31RelatedPartyTransactionDomain11UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain12UNIHEALTH2025-09-30RelatedPartyTransactionDomain12UNIHEALTH2026-03-31RelatedPartyTransactionDomain12UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain13UNIHEALTH2025-09-30RelatedPartyTransactionDomain13UNIHEALTH2026-03-31RelatedPartyTransactionDomain13UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain14UNIHEALTH2025-09-30RelatedPartyTransactionDomain14UNIHEALTH2026-03-31RelatedPartyTransactionDomain14UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain15UNIHEALTH2025-09-30RelatedPartyTransactionDomain15UNIHEALTH2026-03-31RelatedPartyTransactionDomain15UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain16UNIHEALTH2025-09-30RelatedPartyTransactionDomain16UNIHEALTH2026-03-31RelatedPartyTransactionDomain16UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain17UNIHEALTH2025-09-30RelatedPartyTransactionDomain17UNIHEALTH2026-03-31RelatedPartyTransactionDomain17UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain18UNIHEALTH2025-09-30RelatedPartyTransactionDomain18UNIHEALTH2026-03-31RelatedPartyTransactionDomain18UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain19UNIHEALTH2025-09-30RelatedPartyTransactionDomain19UNIHEALTH2026-03-31RelatedPartyTransactionDomain19UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain20UNIHEALTH2025-09-30RelatedPartyTransactionDomain20UNIHEALTH2026-03-31RelatedPartyTransactionDomain20UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain21UNIHEALTH2025-09-30RelatedPartyTransactionDomain21UNIHEALTH2026-03-31RelatedPartyTransactionDomain21UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain22UNIHEALTH2025-09-30RelatedPartyTransactionDomain22UNIHEALTH2026-03-31RelatedPartyTransactionDomain22UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain23UNIHEALTH2025-09-30RelatedPartyTransactionDomain23UNIHEALTH2026-03-31RelatedPartyTransactionDomain23UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain24UNIHEALTH2025-09-30RelatedPartyTransactionDomain24UNIHEALTH2026-03-31RelatedPartyTransactionDomain24UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain25UNIHEALTH2025-09-30RelatedPartyTransactionDomain25UNIHEALTH2026-03-31RelatedPartyTransactionDomain25UNIHEALTH2025-10-012026-03-31RelatedPartyTransactionDomain26UNIHEALTH2025-09-30RelatedPartyTransactionDomain26UNIHEALTH2026-03-31RelatedPartyTransactionDomain26UNIHEALTH2026-03-31Statement1UNIHEALTH2025-10-012026-03-31Statement1UNIHEALTH2026-03-31Statement2UNIHEALTH2025-10-012026-03-31Statement2UNIHEALTH2026-03-31StatementDynamic1I1Statement1UNIHEALTH2026-03-31StatementDynamic1I2Statement1UNIHEALTH2026-03-31StatementDynamic1I3Statement1UNIHEALTH2026-03-31StatementDynamic1I4Statement1UNIHEALTH2026-03-31StatementDynamic1I5Statement1UNIHEALTH2026-03-31StatementDynamic1I6Statement1UNIHEALTH2026-03-31StatementDynamic2I1Statement2UNIHEALTH2026-03-31StatementDynamic2I2Statement2iso4217:INRxbrli:pureiso4217:INRxbrli:shares000000UNIHEALTHNOTLISTEDINE0PRF01011UNIHEALTH HOSPITALS LIMITEDSMEEquity2025-04-012026-03-312026-05-292026-05-21INRLakhsHalf YearlyYearlyGeographical2026-05-2915:00:002026-05-2918:00:00trueCash Flow IndirectNot applicabletruetrueNANAfalsetrue2025-05-23https://www.unihealthonline.com/codes-policiestrue2falseNot Applicable2025-10-012026-03-31AuditedStandalone3670600040294000770000000756600008970000217000113800072920002518300051817000051817000140070001440001415100003766600000003766600087400038540000157000000102.492.46002.492.46NOTES : <br /> <br /> 1.This is the first period for which the Company has prepared financial results in compliance with Ind AS. Prior to April 1, 2025, the Company had prepared its Financial Statement in accordance with the Accounting Standards notified under 133 of the Companies Act, 2013, read with Rule 7 of the Companies (Accounts) Rules, 2014 (Previous GAAP). <br /> <br /> 2.The Company has adopted Ind AS (Indian Accounting Standards) w.e.f April 1, 2025. The Reconciliation of Net Profit reported in accordance with Previous GAAP to total comprehensive Income in accordance with Ind AS for the year and half year ended 31st March, 2025 is given below. <br /> <br /> Particulars Half-Year Ended on 31st March 2025 (Audited) Year Ended on 31st March 2025 (Audited) <br /> Consolidated Standalone Consolidated Standalone <br /> Net Profit for the period under previous Indian GAAP 997.23 120.62 1514.61 233.37 <br /> Adjustements on account of : <br /> Employee benefit expense 1.49 1.49 2.81 2.81 <br /> Interest Income 3.20 0.19 3.38 0.37 <br /> Interest expense on security deposit (0.16) (0.16) (0.32) (0.32) <br /> Interest expense on lease (20.39 ) - (25.93) - <br /> Rent expense 64.76 - 94.19 - <br /> Depreciation (136.01) - (161.03) - <br /> Tax (3.34) (2.42) (12.44) (1.31) <br /> Conversion of JV to Subsidiary on account of IND AS 907.40 - 1303.24 - <br /> FCTR (2.82) - (6.03) - <br /> Net Profit for the period as per IND AS 1811.36 119.72 2,712.48 234.92 <br /> <br /> <br /> 3.The Company has adopted Ind AS (Indian Accounting Standards) w.e.f April 1, 2025. The Reconciliation of Equity as reported in accordance with Previous GAAP and in accordance with Ind AS for the year ended 31st March, 2025 is given below. <br /> <br /> Particulars Year Ended on 31st March 2025 (Audited) <br /> Consolidated Standalone <br /> Equity as reported under previous Indian GAAP 8809.72 5,140.71 <br /> Adjustements on account of : <br /> Items reclassified to Other Comprehensive Incom (8.71) (11.53) <br /> Deferred Tax (3.34) 2.93 <br /> Change in Control Assessment (10.26) <br /> FCTR (191.26) <br /> Equity for the period as per IND AS 8,596.15 5,132.10 <br /> <br /> 4.The standalone/Consolidated financial results of the company have been prepared in, accordance with Indian Accounting standards (Ind AS) as prescribed under section 133 of the companies Act 2013 read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (LODR) Regulation, 2015. The company has also reclassified the previous figures in accordance with the requirements applicable in the current period. <br /> <br /> 5.The standalone financial results ("the Statement") of the Company for the Half year and year ended March 31, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meetings held on May 29, 2026 .The statutory auditors, have expressed an unmodified review conclusion on the standalone financial results for the Half year ended March 31, 2026 and have expressed an unmodified audit opinion on the financial results for the year ended March 31, 2026.The Statutory Auditors have conducted audit of the above mentioned half yearly financial results of March 31, 2026, as required by regulation 33 of SEBI (LODR) regulations, 2015. <br /> 6.Basic earnings per share are calculated by dividing the profit after Tax for the period attributable to equity shareholders by the weighted average number of equity shares outstanding during the period. The net profit for the period attributable to equity shareholders and the weighted average number of shares outstanding during the period are adjusted for the effects of 4 lakh number of equity share warrants amouting to Rs.604 lakhs outstanding at the end of the year for computing dilutive potential equity shares. <br /> 7.The Figures for half year ended 31 st March 2026 are the balancing figures between the audited figures in respect of Financial year 2025-26 and the Published unaudited figures of Hald year ended september 30,2025 , which were subject to limited review. <br /> <br /> 8.During the year investment in UHS Oncology Private Limited ( Associate Company) amounting to Rs.0.33 Lakhs was redeemed during the year. <br /> 9.The Company has alloted 7 lakhs convertible warrants on 2nd May, 2025 as approved by Shareholders at the Extra Ordinary General Meeting held on 09.04.2025.The company has already converted 3 lakhs warrants into equity shares during the year. The balance 4 lakhs warrants are outstanding and the company has received the 25% of the issue price for such warrants. The warrants are convertible into equal number of equity share and the conversion option can be exercised at any time during the period of 18 months from the date of allotement of the said warrants. <br /> <br /> 10.The aforesaid results have been filed with Stock Exchanges under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are also available on the Stock Exchanges websites and on the website of the Company. <br /> 11.The Company is not a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P /2018/144 dated 26th November, 2018. <br /> 12.There are no investors complaints pending as on 31 March, 2026. <br /> 13.Segment information is presented in the "Consolidated Financial Results" as permitted under the Ind AS 108 -'Operating Segments'. <br /> <br /> 14.Figures for the previous periods /year have been regrouped, restated and /or reclassified wherever considered necessary to make them comparable to the current periods /presentation. <br /> 15.The proceeds from the Equity shares IPO issued during FY 23-24 was amounting to Rs 5654.88 lakhs. The object and proposed utilization of IPO Proceeds and amount utilized as on March 31, 2026 is as under:- <br /> Object Amount Utilized (Rs. in lakhs) <br /> Investment in our joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHL 1700.00 <br /> Investment in our joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for proposed expansion 290.30 <br /> Investment in our subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for proposed expansion* 237.50 <br /> Investment in our subsidiaries UMC Hospitals Private Limited (India) and in Unihealth Holdings Limited (Mauritius) to support expansion and acquisition of projects across India and Africa* 1350.00 <br /> General Corporate Purpose 1093.08 <br /> Issue Expenses 814.30 <br /> <br /> <br /> * The original object as disclosed in the offer document was further altered by passing a resolution to vary the utilisation of proceeds raised by the Company through an initial public offering of equity shares (the 'IPO') made in pursuance of the Prospectus dated September 14, 2023 (the 'Prospectus') and reallocate the unutilized proceeds for the objects as set out in the Postal Ballot Notice, have been passed with requisite majority on Wednesday, June 26, 2024. Out of initial proposed amount i.e. Rs. 1587.50 Lakhs, Rs.1350 Lakhs were reallocated for investing as equity and debt in UMC Hospitals Private Limited, a subsidiary of the Company in India and in Unihealth Holdings Limited, the wholly owned subsidiary of the Company in Mauritius, to support expansion and acquisition of projects across India and Africa, in furtherance of the current objects of the Company. <br /> 2025-04-012026-03-31AuditedStandalone6539600066889000132285000075660000176720001044000238100015321000439840008830100008830100023300000880002338800006491300000006491300070800065621000157000000106362320004.194.15004.194.15Other Expenses7292000Other Expenses1532100028735000000252000000304940000369326000547000674813000070380000000456330003099800000241880001008190000130790001138980008176980001570000006362320007932320007932320000000024170007970000321400001976000551000252700042150006742000462000140480002125200024466000817698000Others547000Others24188000Other current assets13079000Other current financial liabilities4215000Other current liabilities462000India159612000Uganda520257000Tanzania-561000Nigeria6240000Mauritius1170000UAE44224000India249498000Uganda1152688000Tanzania1979000Nigeria7246000Mauritius2611000UAE44224000730942000145824600056461000881230006744810001370123000India-28249000Uganda151989000Tanzania-1154000Nigeria2820000Mauritius-883000UAE42546000India-9084000Uganda436966000Tanzania-5359000Nigeria-1970000Mauritius263000UAE421250001670690004629410000000167069000462941000India1276650000Uganda1632879000Tanzania64881000Nigeria75061000Mauritius46362000UAE1266820003222515000-6809130002541602000India471025000Uganda425219000Tanzania83302000Nigeria39131000Mauritius632000UAE21080001021417000-45939600056202100010440000-165610000000-422000012350000-700002381000012214000015560000-10370000000000000-89300007937100000-1577800023300000040293000000000000-940000000000000040033000011001000000001577800000-541050000045300000151000000000026550000000093260004317600029364000029364000163400030998000-874000-70800000874000708000Unihealth Hospitals Limited******UMC Hospital Pvt Ltd******Subsidiary CompanyLoanApproved by Audit commiitee where required5945000064200000123650000Loan0NALoan0.125 yearsUnsecuredWorking CapitalUnihealth Hospitals Limited******UMC Hospital Pvt Ltd******Subsidiary CompanyInterest receivedApproved by Audit commiitee where required50720005060000Unihealth Hospitals Limited******UMC Hospital Pvt Ltd******Subsidiary CompanyAny other transactionManagement FeesApproved by Audit commiitee where required3330000333000Unihealth Hospitals Limited******UMC Hospital Pvt Ltd******Subsidiary CompanyAny other transactionCommission IncomeApproved by Audit commiitee where required179200001792000Unihealth Hospitals Limited******Unihealth Pharmceuticals Pvt Ltd******Subsidiary CompanyLoanApproved by Audit commiitee where required500000000Loan0NALoan0.123 yearsUnsecuredWorking CapitalUnihealth Hospitals Limited******Unihealth Pharmceuticals Pvt Ltd******Subsidiary CompanyAny other transactionLoan RepaidApproved by Audit commiitee where required500000000Unihealth Hospitals Limited******Unihealth Pharmceuticals Pvt Ltd******Subsidiary CompanyAny other transactionGuarantee Commission IncomeApproved by Audit commiitee where required1100000110000Unihealth Hospitals Limited******Unihealth Pharmceuticals Pvt Ltd******Subsidiary CompanyInterest receivedApproved by Audit commiitee where required8600004000Unihealth Hospitals Limited******Victoria Hospital Limited******Joint Venture of Unihealth Hospitals limitedAny other transactionLoan RepaidApproved by Audit commiitee where required22198000184688000173217000Unihealth Hospitals Limited******Victoria Hospital Limited******Joint Venture of Unihealth Hospitals limitedAny other transactionManagement FeesApproved by Audit commiitee where required9408000118780004090000Unihealth Hospitals Limited******Akshay Mahendra Parmar******KMPRemunerationApproved by Audit commiitee where required420000000Unihealth Hospitals Limited******Parag Shah******KMPRemunerationNA80000000Unihealth Hospitals Limited******Deshna Jain******KMPRemunerationNA5500000Unihealth Hospitals Limited******Binita Patel******KMPRemunerationNA13100000Unihealth Hospitals Limited******Aarzeal Technologies Private Limited******Subsidiary CompanyPurchase of goods or servicesApproved by Audit commiitee where required900090000Unihealth Hospitals Limited******Unihealth Tanzania Limited******Subsidiary CompanyInterest receivedApproved by Audit commiitee where required18800011370001401000Unihealth Hospitals Limited******Biohealth Limited******Subsidiary CompanyInterest receivedApproved by Audit commiitee where required160900042620006153000Unihealth Hospitals Limited******Unihealth (U) Limited******Associates CompanyInterest receivedApproved by Audit commiitee where required212000667000212000Unihealth Hospitals Limited******UMC Global Health Limited******Subsidiary CompanyInterest receivedApproved by Audit commiitee where required174500036180005602000Unihealth Hospitals Limited******UMC Global Health Limited******Subsidiary CompanyLoanApproved by Audit commiitee where required8860002663800029343000Unihealth Pharmceuticals Pvt Ltd******Akshay Mahendra Parmar******Managing DirectorAny other transactionLoan RepaidApproved by Audit commiitee where required730000000Unihealth Pharmceuticals Pvt Ltd******Anurag Shah******DirectorAny other transactionLoan RepaidApproved by Audit commiitee where required163000000Unihealth Pharmceuticals Pvt Ltd******Unihealth (U) Limited******Associate Company of Unihealth Hospitals limitedSale of goods or servicesApproved by Audit commiitee where required206480002227700015654000Unihealth Pharmceuticals Pvt Ltd******Victoria Hospital Limited******Joint Venture of Unihealth Hospitals limitedSale of goods or servicesApproved by Audit commiitee where required25488000427900013696000Unihealth Pharmceuticals Pvt Ltd******UMC Hospital Pvt Ltd******Subsidiary Company of Unihealth Hospitals limitedSale of goods or servicesApproved by Audit commiitee where required7310000140000UMC Hospital Pvt Ltd******Aarzeal Technologies Private Limited******Sister CompaniesPurchase of goods or servicesApproved by Audit commiitee where required206000230000174287000Public Issues2023-09-1556540002026-03-31falsefalseNoneNoneNoneDeshna JainCompany Secretary and Compliance OfficerMumbai2026-05-29Preferential Issues2025-05-0210570002026-03-31falsefalseNoneNoneNoneInvestment in our joint venture, Victoria Hospital Limited (VHL), Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements of VHLNo Modification17000000001700000000Investment in our joint venture, UMC Global Health Limited (UMCGHL), Nigeria for funding its capital expenditure requirements for proposed expansionNo Modification460000000290300000169.70 Unutilized Amount <br /> Investment in our subsidiary, Biohealth Limited (BL), Tanzania for funding its capital expenditure requirements for proposed expansionNo Modification15875000023750000237500000NAInvestment in our subsidiaries namely UMC Hospitals Private Limited (India) and in Unihealth Holdings Limited (Mauritius) to support expansion and acquisition of projects across India and Africa01350000001350000000General Corporate PurposeNo Modification10930800001093080000Issue ExpensesNo Modification814300000814300000Funding to its Subsidiary , UMC Hospitals Private Limited to support Capital Expenditures (CAPEX) and working capital requirement for the hospital in India.NA845600000463730000140.27 - Unutilized amountGeneral Corporate Purpose, which includes, without limitation, strategic initiatives, funding growth opportunities, strengthening marketing capabilities and brand building exercises, meeting ongoing general corporate contingencies, fund raising expense and other expenses incurred in ordinary course of businessNA21140000000